Back to Search Start Over

268MO A phase-Ib study of lucitanib (AL3810) in a cohort of patients with recurrent and metastatic nasopharyngeal carcinoma (NPC).

Authors :
Zhao, H-Y.
Zhang, Y.
Ma, Y-X.
Zhang, L.
Lin, J.
Qin, S.
Source :
Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1348-S1348. 1p.
Publication Year :
2020

Subjects

Subjects :
*NASOPHARYNX cancer patients
*ANTINEOPLASTIC agents

Details

Language :
English
ISSN :
09237534
Volume :
31
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
152684775
Full Text :
https://doi.org/10.1016/j.annonc.2020.10.262
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details